Stomach cancer showdown: surgery or chemo first?
NCT ID NCT01717924
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks at people with a rare type of stomach cancer called signet ring cell adenocarcinoma. It compares two treatment strategies: having surgery first, or having chemotherapy first followed by surgery. The goal is to see which approach helps people live longer and with fewer side effects. About 314 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SIGNET RING CELL GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General and digestive surgical department, Claude Huriez Hospital, University Hospital
RECRUITINGLille, 59037, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.